Advertisement
Screener

VERICEL CORPORATION (VCEL) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

VERICEL CORPORATION Shares Authorized

VERICEL CORPORATION (VCEL) had Shares Authorized of 75.00 million shares as of 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-07-30

  • 2026-06-30: Common Stock, Shares Authorized 75.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 75.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 75.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 75.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-3075.00M shares
10-Q · filed 2026-07-30
2026-03-3175.00M shares
10-Q · filed 2026-05-07
2025-12-3175.00M shares
10-Q · filed 2026-07-30
2025-09-3075.00M shares
10-Q · filed 2025-11-06
2025-06-3075.00M shares
10-Q · filed 2025-07-31
2025-03-3175.00M shares
10-Q · filed 2025-05-08
2024-12-3175.00M shares
10-K · filed 2026-02-26
2024-09-3075.00M shares
10-Q · filed 2024-11-07
2024-06-3075.00M shares
10-Q · filed 2024-08-01
2024-03-3175.00M shares
10-Q · filed 2024-05-08
2023-12-3175.00M shares
10-K · filed 2025-02-27
2023-09-3075.00M shares
10-Q · filed 2023-11-08
2023-06-3075.00M shares
10-Q · filed 2023-08-02
2023-03-3175.00M shares
10-Q · filed 2023-05-10
2022-12-3175.00M shares
10-K · filed 2024-02-29
2022-09-3075.00M shares
10-Q · filed 2022-11-09
2022-06-3075.00M shares
10-Q · filed 2022-08-03
2022-03-3175.00M shares
10-Q · filed 2022-05-04
2021-12-3175.00M shares
10-K · filed 2023-02-23
2021-09-3075.00M shares
10-Q · filed 2021-11-09
2021-06-3075.00M shares
10-Q · filed 2021-08-04
2021-03-3175.00M shares
10-Q · filed 2021-05-05
2020-12-3175.00M shares
10-K · filed 2022-02-24
2020-09-3075.00M shares
10-Q · filed 2020-11-05
2020-06-3075.00M shares
10-Q · filed 2020-08-05
2020-03-3175.00M shares
10-Q · filed 2020-05-11
2019-12-3175.00M shares
10-K · filed 2021-02-24
2019-09-3075.00M shares
10-Q · filed 2019-11-05
2019-06-3075.00M shares
10-Q · filed 2019-08-06
2019-03-3175.00M shares
10-Q · filed 2019-05-07
2018-12-3175.00M shares
10-K · filed 2020-02-25
2018-09-3075.00M shares
10-Q · filed 2018-11-06
2018-06-3075.00M shares
10-Q · filed 2018-08-06
2018-03-3175.00M shares
10-Q · filed 2018-05-08
2017-12-3175.00M shares
10-K · filed 2019-02-26
2017-09-3075.00M shares
10-Q · filed 2017-11-07
2017-06-3075.00M shares
10-Q · filed 2017-08-09
2017-03-3175.00M shares
10-Q · filed 2017-05-10
2016-12-3175.00M shares
10-K · filed 2018-03-05
2016-09-3075.00M shares
10-Q · filed 2016-11-07
2016-06-3075.00M shares
10-Q · filed 2016-08-08
2016-03-3175.00M shares
10-Q · filed 2016-05-10
2015-12-3175.00M shares
10-K · filed 2017-03-13
2015-09-3075.00M shares
10-Q · filed 2015-11-13
2015-06-3075.00M shares
10-Q · filed 2015-08-12
2015-03-3175.00M shares
10-Q · filed 2015-05-14
2014-12-3175.00M shares
10-K · filed 2016-03-14
2014-09-3075.00M shares
10-Q · filed 2014-11-13
2014-06-3075.00M shares
10-Q · filed 2014-08-14
2014-03-3115.00M shares
10-Q · filed 2014-05-15
2013-12-3115.00M shares
10-K · filed 2015-03-25
2013-09-30150.00M shares
10-Q · filed 2013-11-12
2013-06-30150.00M shares
10-Q · filed 2013-08-07
2013-03-31150.00M shares
10-Q · filed 2013-05-08
2012-12-317.50M shares
10-K · filed 2014-03-13
150.00M shares
10-K · filed 2013-03-18
2012-09-30150.00M shares
10-Q · filed 2012-11-08
2012-06-30150.00M shares
10-Q · filed 2012-08-07
2012-03-31150.00M shares
10-Q · filed 2012-05-10
2011-12-31150.00M shares
10-K · filed 2013-03-18
2011-09-30150.00M shares
10-Q · filed 2011-11-08
2011-06-30150.00M shares
10-Q · filed 2011-08-15
2010-12-3162.50M shares
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80